Brief report · 29 Dec 2025
Conference abstractPublished 24 Sep 2014
Advances in clinical studies on anti-tumour and supportive care effects of specific mistletoe preparations: Viscum album [L.] extract therapy versus no antineoplastic therapy in patients with locally advanced or metastat
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: The patients with advanced pancreatic cancer have dismal prognosis. When deciding on specific treatment the impact on the quality of life should be taken into account. Objectives: To compare overall survival (OS) and quality of life (QoL) of patients with locally advanced or metastatic adenocarcinoma of the pancreas receiving Viscum album (L.) (VaL) or no antineoplastic therapy. Methods: The efficacy of VaL (Iscador®Qu special) was tested by a randomized clinical trial including 220 patients. Primary endpoint was OS observed over 12 month. Secondary efficacy parameters included all15 QoL-dimensions of the EORTC QLQ- C30. Tumour-related symptoms and body weight were recorded at each visit. Results: Median OS of VaL versus control was 4.8 vs. 2.7 months (HRadjusted=0.485; p<0.0001). A significant advantage of VaL was observed for 13 of the 15 QoL dimensions (p0.001), with 10 dimensions showing a clinically relevant improvement of ≥ 10 units. Analysis of tumour-related symptoms, and change in body weight (post-hoc), confirmed the favourable effects on QoL. No VaL-related adverse event (AE) or serious AE were observed. Conclusions: VaL therapy led to a relevant increase of OS and quality of life without causing any side-effects. VaL may provide a comprehensive second-line therapy for advanced pancreatic cancer patients
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Tissue Science and Engineering.
Opinion · 29 Dec 2025
Biomaterials, Cells, And Stimulation For Spinal Cord Repair
Brief report · 29 Dec 2025
Cardiac Tissue Engineering: Building a New Heart
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Tissue Science and Engineering
- SubjectEngineering
- BylineArticles whose byline prints “Daniel Galun”
